300583.SZ
Shandong Sito Bio-technology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.72
−1.32%Sep 3, 2026, 10:00 UTC
Saituo Biotech filed a criminal complaint against former employee Qi for trade secret theft, who was arrested on August 31, 2026, and also filed a civil lawsuit seeking 320 million yuan in damages against Shenyang Botai Biopharmaceutical and four individuals.
Source:Sep 3, 2026, 07:57 UTC
Saituo Biologics announced that its former employee Qi was arrested on suspicion of stealing trade secrets, a criminal case related to a previously disclosed civil lawsuit seeking 320 million yuan in damages.
Source:Aug 28, 2026, 08:53 UTC
Saitobio announced its first-half 2026 results: net profit attributable to shareholders was 30.2274 million yuan, turning from a loss in the same period last year.
Source:Aug 24, 2026, 08:48 UTC
Saituo Biotech and its subsidiary Sirui Pharma were sued by Xinhexin for patent infringement involving 226 million yuan, and one of the two disputed patents was declared wholly invalid by the China National Intellectual Property Administration.
Source:Jul 22, 2026, 08:04 UTC
Saituo Biotechnology's controlling subsidiary Shandong Sirui Pharmaceutical received China's National Medical Products Administration approval for the active pharmaceutical ingredient fluticasone furoate.
Source: